Equinor ASA
Equinor ASA (STOHF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Equinor ASA (STOHF), featuring income statements, balance sheets, and cash flow data.
Equinor ASA (STOHF) Income Statement & Financial Overview
View the income breakdown for Equinor ASA STOHF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $29.38B | $26.54B | $25.42B | $25.46B |
| Cost of Revenue | $17.75B | $15.69B | $15.42B | $14.49B |
| Gross Profit | $11.63B | $10.84B | $9.99B | $10.97B |
| Gross Profit Ratio | $0.40 | $0.41 | $0.39 | $0.43 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $323.00M | $261.00M | $304.00M | $348.00M |
| Operating Expenses | $2.76B | $2.11B | $3.09B | $3.32B |
| Total Costs & Expenses | $20.51B | $17.80B | $18.51B | $17.82B |
| Interest Income | $336.00M | $286.00M | $460.00M | $495.00M |
| Interest Expense | $325.00M | -$124.00M | $370.00M | $394.00M |
| Depreciation & Amortization | $2.31B | $2.81B | $2.33B | $2.35B |
| EBITDA | $11.53B | $10.87B | $9.97B | $10.27B |
| EBITDA Ratio | $0.39 | $0.41 | $0.39 | $0.40 |
| Operating Income | $8.87B | $8.73B | $6.91B | $7.66B |
| Operating Income Ratio | $0.30 | $0.33 | $0.27 | $0.30 |
| Other Income/Expenses (Net) | $19.00M | -$547.00M | $366.00M | -$126.00M |
| Income Before Tax | $8.89B | $8.19B | $7.27B | $7.53B |
| Income Before Tax Ratio | $0.30 | $0.31 | $0.29 | $0.30 |
| Income Tax Expense | $6.26B | $6.19B | $4.99B | $5.66B |
| Net Income | $2.63B | $2.00B | $2.28B | $1.86B |
| Net Income Ratio | $0.09 | $0.08 | $0.09 | $0.07 |
| EPS | $0.95 | $0.73 | $0.83 | $0.65 |
| Diluted EPS | $0.96 | $0.72 | $0.82 | $0.65 |
| Weighted Avg Shares Outstanding | $2.76B | $2.76B | $2.76B | $2.86B |
| Weighted Avg Shares Outstanding (Diluted) | $2.75B | $2.75B | $2.77B | $2.86B |
The company's financials show resilient growth, with revenue advancing from $25.46B in Q2 2024 to $29.38B in Q1 2025. Gross profit remained healthy with margins at 40% in Q1 2025 compared to 43% in Q2 2024. Operating income hit $8.87B last quarter, sustaining a consistent 30% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $11.53B. Net income rose to $2.63B, while earnings per share reached $0.95. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan